Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baotou Dongbao Bio-Tech is a leading high-tech enterprise based in China that specializes in the research, development, and industrial production of gelatin and collagen-based products. The company’s primary offerings include medicinal gelatin for hard and soft capsules, edible gelatin, and high-purity collagen peptides marketed for bone and skin health. As a key player in the pharmaceutical excipient and nutraceutical sectors, Dongbao Bio-Tech operates advanced manufacturing facilities that adhere to international quality standards. The company is particularly recognized for its 'Yuan Su' brand of collagen peptides and its significant R&D focus on bioactive peptides and biomaterials. Listed on the Shenzhen Stock Exchange, it serves a global clientele across the pharmaceutical, food, and cosmetic industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baotou Dongbao Bio-Tech.